Income Statement CorVel Corporation

Stocks

CRVL

US2210061097

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 12:01:36 03/09/2026 am IST			5-day change	1st Jan Change
70.90 ^USD	+1.66%		+0.58%	+4.58%

05/08	CorVel Corporation, Q1 2027 Earnings Call, Aug 05, 2026
05/08	Tranche Update on CorVel Corporation's Equity Buyback Plan announced on November 12, 1996.	CI

a908.43U6N5r1la43khcrwD1JDPJ_mR5Xr_kRl5MBJJ0f-Wo.hTRPY_Ci79le4C5cj3MaOYMF2FAc16pX_-NjRdItnyCrA3xv46T0wE3fcA

Published financial data: CORVEL CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Revenues	65Cr	72Cr	80Cr	90Cr	96Cr
Total Revenues	65Cr	72Cr	80Cr	90Cr	96Cr
Cost of Goods Sold, Total	49Cr	56Cr	62Cr	69Cr	73Cr
Gross Profit	15Cr	16Cr	17Cr	21Cr	23Cr
Selling General & Admin Expenses, Total	6.76Cr	7.37Cr	7.66Cr	8.89Cr	8.97Cr
Other Operating Expenses, Total	6.76Cr	7.37Cr	7.66Cr	8.89Cr	8.97Cr
Operating Income	8.45Cr	8.46Cr	9.51Cr	12Cr	14Cr
EBT, Excl. Unusual Items	8.45Cr	8.46Cr	9.51Cr	12Cr	14Cr
EBT, Incl. Unusual Items	8.45Cr	8.46Cr	9.51Cr	12Cr	14Cr
Income Tax Expense	1.81Cr	1.82Cr	1.88Cr	2.57Cr	3.28Cr
Earnings From Continuing Operations	6.64Cr	6.64Cr	7.63Cr	9.52Cr	11Cr
Net Income to Company	6.64Cr	6.64Cr	7.63Cr	9.52Cr	11Cr
Net Income - (IS)	6.64Cr	6.64Cr	7.63Cr	9.52Cr	11Cr
Net Income to Common Incl Extra Items	6.64Cr	6.64Cr	7.63Cr	9.52Cr	11Cr
Net Income to Common Excl. Extra Items	6.64Cr	6.64Cr	7.63Cr	9.52Cr	11Cr
Per Share Items
Net EPS - Basic	1.25	1.28	1.48	1.85	2.15
Basic EPS - Continuing Operations	1.25	1.28	1.48	1.85	2.15
Basic Weighted Average Shares Outstanding	5.33Cr	5.2Cr	5.14Cr	5.14Cr	5.13Cr
Net EPS - Diluted	1.22	1.26	1.47	1.83	2.14
Diluted EPS - Continuing Operations	1.22	1.26	1.47	1.83	2.14
Diluted Weighted Average Shares Outstanding	5.44Cr	5.28Cr	5.2Cr	5.2Cr	5.16Cr
Normalized Basic EPS	0.99	1.02	1.16	1.47	1.74
Normalized Diluted EPS	0.97	1	1.14	1.45	1.73
Supplemental Items
EBITDA	11Cr	11Cr	12Cr	15Cr	17Cr
EBITA	8.49Cr	8.5Cr	9.55Cr	12Cr	14Cr
EBIT	8.45Cr	8.46Cr	9.51Cr	12Cr	14Cr
EBITDAR	12Cr	12Cr	13Cr	16Cr	18Cr
Effective Tax Rate - (Ratio)	21.42	21.51	19.82	21.24	22.91
Current Domestic Taxes	1.58Cr	2.01Cr	2.22Cr	3.08Cr	2.8Cr
Total Current Taxes	1.58Cr	2.01Cr	2.22Cr	3.08Cr	2.8Cr
Deferred Domestic Taxes	23.02L	-19.13L	-33.21L	-51.59L	47.8L
Total Deferred Taxes	23.02L	-19.13L	-33.21L	-51.59L	47.8L
Normalized Net Income	5.28Cr	5.28Cr	5.94Cr	7.55Cr	8.95Cr
Supplemental Operating Expense Items
General and Administrative Expenses	6.76Cr	7.37Cr	7.66Cr	8.89Cr	8.97Cr
Net Rental Expense, Total	1.43Cr	1.28Cr	1.07Cr	98.49L	88.13L
Stock-Based Comp., COGS (Total)	20.63L	25.66L	27.97L	27.94L	26.41L
Stock-Based Comp., G&A Exp. (Total)	31.35L	29.93L	21.85L	29.2L	27.7L
Total Stock-Based Compensation	51.98L	55.59L	49.82L	57.14L	54.11L

Fiscal Period: March	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Assets
Cash And Equivalents	9.75Cr	7.13Cr	11Cr	17Cr	23Cr
Total Cash And Short Term Investments	9.75Cr	7.13Cr	11Cr	17Cr	23Cr
Accounts Receivable, Total	8.26Cr	8.1Cr	9.71Cr	10Cr	10Cr
Total Receivables	8.26Cr	8.1Cr	9.71Cr	10Cr	10Cr
Prepaid Expenses	1.28Cr	95.69L	92.49L	1.05Cr	1.09Cr
Other Current Assets, Total	7.21Cr	8.18Cr	9.03Cr	10Cr	12Cr
Total Current Assets	26Cr	24Cr	30Cr	39Cr	46Cr
Gross Property Plant And Equipment	16Cr	15Cr	14Cr	14Cr	35Cr
Accumulated Depreciation	-7.6Cr	-7.36Cr	-6.7Cr	-7.14Cr	-26Cr
Net Property Plant And Equipment	8.15Cr	7.68Cr	7.28Cr	7.01Cr	8.95Cr
Long-term Investments	-	-	-	-	-
Goodwill	3.68Cr	3.68Cr	3.68Cr	3.68Cr	3.68Cr
Other Intangibles, Total	3.15Cr	3.49Cr	3.8Cr	4.32Cr	4.98Cr
Deferred Tax Assets Long-Term	-	2L	35.45L	87.04L	39.24L
Other Long-Term Assets, Total	5L	13.8L	13.18L	5L	6L
Total Assets	42Cr	39Cr	45Cr	55Cr	64Cr
Liabilities
Accounts Payable, Total	1.41Cr	1.51Cr	1.64Cr	1.54Cr	2.43Cr
Accrued Expenses, Total	4.8Cr	3.57Cr	4.09Cr	4.68Cr	4.82Cr
Current Portion of Leases	1.33Cr	99L	88.64L	81.26L	74.2L
Current Income Taxes Payable	-	3L	2L	13.7L	2L
Unearned Revenue Current, Total	2.58Cr	2.7Cr	3Cr	3.08Cr	3.22Cr
Other Current Liabilities	7.01Cr	8Cr	8.81Cr	10Cr	12Cr
Total Current Liabilities	17Cr	17Cr	18Cr	20Cr	23Cr
Long-Term Leases	2.98Cr	2.39Cr	2.25Cr	2Cr	2.07Cr
Deferred Tax Liability Non Current	16.89L	-	-	-	-
Total Liabilities	20Cr	19Cr	21Cr	22Cr	25Cr
Common Stock, Total	3T	3T	3T	5T	5T
Additional Paid In Capital	20Cr	22Cr	23Cr	25Cr	27Cr
Retained Earnings	67Cr	73Cr	81Cr	90Cr	101.34Cr
Treasury Stock	-65Cr	-75Cr	-79Cr	-83Cr	-89Cr
Total Common Equity	21Cr	20Cr	25Cr	32Cr	39Cr
Total Equity	21Cr	20Cr	25Cr	32Cr	39Cr
Total Liabilities And Equity	42Cr	39Cr	45Cr	55Cr	64Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.25Cr	5.14Cr	5.14Cr	5.14Cr	5.07Cr
ECS Total Common Shares Outstanding	5.27Cr	5.15Cr	5.14Cr	5.14Cr	5.09Cr
Book Value / Share	4.03	3.93	4.82	6.27	7.74
Tangible Book Value	14Cr	13Cr	17Cr	24Cr	31Cr
Tangible Book Value Per Share	2.73	2.53	3.36	4.71	6.04
Total Debt	4.31Cr	3.38Cr	3.14Cr	2.81Cr	2.81Cr
Net Debt	-5.44Cr	-3.76Cr	-7.42Cr	-14Cr	-20Cr
Debt Equivalent Oper. Leases	11Cr	10Cr	8.53Cr	7.88Cr	7.05Cr
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	1.11Cr	1.11Cr	1.11Cr	1.1Cr	1.1Cr
Machinery, Total	7.74Cr	6.83Cr	6.66Cr	6.54Cr	7.68Cr
Full Time Employees	4.23T	4.44T	4.87T	5.08T	5.24T
Accumulated Allowance for Doubtful Accounts (Supple)	25.62L	28.23L	42.45L	76.9L	39.69L

Fiscal Period: March	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Net Income	6.64Cr	6.64Cr	7.63Cr	9.52Cr	11Cr
Depreciation & Amortization - CF	2.35Cr	2.47Cr	2.58Cr	2.92Cr	3.16Cr
Amortization of Goodwill and Intangible Assets - (CF)	4L	4L	4L	4L	2L
Depreciation & Amortization, Total	2.39Cr	2.51Cr	2.63Cr	2.95Cr	3.18Cr
Asset Writedown & Restructuring Costs	1L	4L	3L	4L	7L
Stock-Based Compensation (CF)	51.98L	55.59L	49.82L	57.14L	54.11L
Provision and Write-off of Bad Debts	2L	12.16L	18.28L	34.45L	1L
Other Operating Activities, Total	23.02L	-19.13L	-33.21L	-51.59L	47.8L
Change In Accounts Receivable	-1.8Cr	3L	-1.79Cr	-1.05Cr	26.98L
Change In Accounts Payable	14.23L	-43.95L	13.22L	2L	-7L
Change in Other Net Operating Assets	-1.43Cr	-1.04Cr	95.34L	84.72L	5L
Cash from Operations	6.72Cr	8.23Cr	9.92Cr	13Cr	16Cr
Capital Expenditure	-2.98Cr	-2.63Cr	-2.92Cr	-3.58Cr	-4.54Cr
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	-2.98Cr	-2.63Cr	-2.92Cr	-3.58Cr	-4.54Cr
Issuance of Common Stock	1.05Cr	1.15Cr	99.47L	1.11Cr	84.11L
Repurchase of Common Stock	-9.01Cr	-9.37Cr	-4.57Cr	-3.76Cr	-5.62Cr
Cash from Financing	-7.96Cr	-8.21Cr	-3.58Cr	-2.65Cr	-4.78Cr
Net Change in Cash	-4.22Cr	-2.62Cr	3.42Cr	6.5Cr	6.25Cr
Supplemental Items
Cash Income Tax Paid (Refund)	1.94Cr	2Cr	2.29Cr	2.81Cr	3.11Cr
Levered Free Cash Flow	2.22Cr	5.22Cr	5.49Cr	7.58Cr	9.29Cr
Unlevered Free Cash Flow	2.22Cr	5.22Cr	5.49Cr	7.58Cr	9.29Cr
Change In Net Working Capital	2.99Cr	49.86L	65.79L	-8L	-1.16Cr

Fiscal Period: March	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Profitability
Return on Assets	12.58	13.06	14.01	15.09	15.05
Return on Total Capital	19.91	21.51	23.08	24.01	23.16
Return On Equity %	30.69	32.02	33.9	33.41	30.81
Return on Common Equity	30.69	32.02	33.9	33.41	30.81
Margin Analysis
Gross Profit Margin %	23.54	22.02	21.59	23.42	24.29
SG&A Margin	10.46	10.26	9.63	9.93	9.36
EBITDA Margin %	16.78	15.26	15.26	16.79	18.25
EBITA Margin %	13.14	11.83	12.01	13.53	14.95
EBIT Margin %	13.08	11.77	11.96	13.49	14.93
Income From Continuing Operations Margin %	10.28	9.24	9.59	10.63	11.51
Net Income Margin %	10.28	9.24	9.59	10.63	11.51
Net Avail. For Common Margin %	10.28	9.24	9.59	10.63	11.51
Normalized Net Income Margin	8.17	7.35	7.47	8.43	9.33
Levered Free Cash Flow Margin	3.43	7.27	6.9	8.47	9.69
Unlevered Free Cash Flow Margin	3.43	7.27	6.9	8.47	9.69
Asset Turnover
Asset Turnover	1.54	1.78	1.87	1.79	1.61
Fixed Assets Turnover	7.62	9.08	10.63	12.53	12.01
Receivables Turnover (Average Receivables)	8.77	8.78	8.93	8.9	9.33
Short Term Liquidity
Current Ratio	1.55	1.45	1.64	1.9	2.03
Quick Ratio	1.05	0.91	1.1	1.35	1.47
Operating Cash Flow to Current Liabilities	0.39	0.49	0.54	0.62	0.68
Days Sales Outstanding (Average Receivables)	41.6	41.56	40.99	41.01	39.11
Average Days Payable Outstanding	9.76	9.49	9.23	8.47	10
Long Term Solvency
Total Debt/Equity	20.31	16.7	12.68	8.72	7.13
Total Debt / Total Capital	16.88	14.31	11.25	8.02	6.66
LT Debt/Equity	14.03	11.8	9.1	6.2	5.25
Long-Term Debt / Total Capital	11.66	10.11	8.08	5.7	4.9
Total Liabilities / Total Assets	48.85	48.68	45.53	41.03	38.69
Total Debt / EBITDA	0.35	0.28	0.24	0.18	0.15
Net Debt / EBITDA	-0.44	-0.31	-0.56	-0.89	-1.12
Total Debt / (EBITDA - Capex)	0.46	0.35	0.31	0.23	0.2
Net Debt / (EBITDA - Capex)	-0.59	-0.39	-0.72	-1.15	-1.48
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.93	11.19	10.68	12.61	7.03
Gross Profit, 1 Yr. Growth %	23.05	4.04	8.49	22.15	11.03
EBITDA, 1 Yr. Growth %	31.25	1.15	10.65	23.9	16.32
EBITA, 1 Yr. Growth %	42.5	0.04	12.41	26.89	18.23
EBIT, 1 Yr. Growth %	42.82	0.05	12.47	27.05	18.46
Earnings From Cont. Operations, 1 Yr. Growth %	43.26	-0.07	14.9	24.8	15.95
Net Income, 1 Yr. Growth %	43.26	-0.07	14.9	24.8	15.95
Normalized Net Income, 1 Yr. Growth %	42.82	0.05	12.47	27.05	18.46
Diluted EPS Before Extra, 1 Yr. Growth %	43.53	3.01	16.71	24.49	16.94
Accounts Receivable, 1 Yr. Growth %	27.6	-1.88	19.84	7.23	-2.7
Net Property, Plant and Equip., 1 Yr. Growth %	-7.45	-5.75	-5.22	-3.66	27.62
Total Assets, 1 Yr. Growth %	-2.24	-5.14	15.42	20.08	17.77
Tangible Book Value, 1 Yr. Growth %	-6.17	-9.5	32.53	40	27.11
Common Equity, 1 Yr. Growth %	-3.63	-4.81	22.49	30.02	22.44
Cash From Operations, 1 Yr. Growth %	-28.77	22.41	20.6	28.29	22.25
Capital Expenditures, 1 Yr. Growth %	72.93	-11.73	11.09	22.28	26.85
Levered Free Cash Flow, 1 Yr. Growth %	-70	135.47	5.04	38.27	22.47
Unlevered Free Cash Flow, 1 Yr. Growth %	-70	135.47	5.04	38.27	22.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.46	14.03	10.94	11.64	9.78
Gross Profit, 2 Yr. CAGR %	9.91	13.14	6.24	15.12	16.46
EBITDA, 2 Yr. CAGR %	14.14	15.22	5.79	17.09	20.05
EBITA, 2 Yr. CAGR %	17.87	19.4	6.04	19.43	22.48
EBIT, 2 Yr. CAGR %	17.98	19.54	6.08	19.54	22.68
Earnings From Cont. Operations, 2 Yr. CAGR %	18.39	19.65	7.15	19.75	20.3
Net Income, 2 Yr. CAGR %	18.39	19.65	7.15	19.75	20.3
Normalized Net Income, 2 Yr. CAGR %	17.98	19.54	6.08	19.54	22.68
Diluted EPS Before Extra, 2 Yr. CAGR %	19.8	21.59	9.65	20.51	20.66
Accounts Receivable, 2 Yr. CAGR %	12.06	11.89	8.44	13.36	2.14
Net Property, Plant and Equip., 2 Yr. CAGR %	-23.36	-6.6	-5.49	-4.44	10.88
Total Assets, 2 Yr. CAGR %	-0.12	-3.7	4.64	17.73	18.92
Tangible Book Value, 2 Yr. CAGR %	8.46	-7.85	9.52	36.21	33.4
Common Equity, 2 Yr. CAGR %	5.81	-4.22	7.98	26.2	26.17
Cash From Operations, 2 Yr. CAGR %	-8.8	-6.63	21.5	24.39	25.23
Capital Expenditures, 2 Yr. CAGR %	-4.01	23.55	-0.98	16.55	24.55
Levered Free Cash Flow, 2 Yr. CAGR %	-19.41	-15.95	57.27	20.52	30.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	-19.41	-15.95	57.27	20.52	30.13
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.75	6.66	12.9	11.49	10.08
Gross Profit, 3 Yr. CAGR %	6.82	7.92	11.57	11.3	13.74
EBITDA, 3 Yr. CAGR %	8.67	9.63	13.68	11.51	16.83
EBITA, 3 Yr. CAGR %	11.1	11.6	17.02	12.58	19.03
EBIT, 3 Yr. CAGR %	11.17	11.67	17.13	12.65	19.18
Earnings From Cont. Operations, 3 Yr. CAGR %	12.45	11.89	18.05	12.74	18.47
Net Income, 3 Yr. CAGR %	12.45	11.89	18.05	12.74	18.47
Normalized Net Income, 3 Yr. CAGR %	11.17	11.67	17.13	12.65	19.18
Diluted EPS Before Extra, 3 Yr. CAGR %	14.16	13.92	19.94	14.47	19.31
Accounts Receivable, 3 Yr. CAGR %	5	7.21	14.48	8.03	7.73
Net Property, Plant and Equip., 3 Yr. CAGR %	33.27	-17.89	-6.15	-4.88	5.23
Total Assets, 3 Yr. CAGR %	9.3	-1.82	2.29	9.55	17.74
Tangible Book Value, 3 Yr. CAGR %	4.18	2.11	4.02	18.86	33.11
Common Equity, 3 Yr. CAGR %	2.92	2.14	3.96	14.88	24.93
Cash From Operations, 3 Yr. CAGR %	-5.09	0.6	1.69	23.72	23.67
Capital Expenditures, 3 Yr. CAGR %	24.98	-6.65	19.25	6.24	19.89
Levered Free Cash Flow, 3 Yr. CAGR %	-25.3	15.21	-9.47	50.67	21.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	-25.3	15.21	-9.47	50.67	21.17
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.5	5.17	5.95	8.62	11.64
Gross Profit, 5 Yr. CAGR %	7.74	8.09	6.59	10.74	13.5
EBITDA, 5 Yr. CAGR %	9.62	9.5	7.51	12.56	16.18
EBITA, 5 Yr. CAGR %	12.31	12.15	9.05	14.67	19.18
EBIT, 5 Yr. CAGR %	12.19	12.04	9.1	14.76	19.32
Earnings From Cont. Operations, 5 Yr. CAGR %	17.64	13.21	10.3	14.97	18.94
Net Income, 5 Yr. CAGR %	17.64	13.21	10.3	14.97	18.94
Normalized Net Income, 5 Yr. CAGR %	12.19	12.04	9.1	14.76	19.32
Diluted EPS Before Extra, 5 Yr. CAGR %	19.37	15.06	12.33	16.58	20.28
Accounts Receivable, 5 Yr. CAGR %	5.62	4.53	6.36	9.63	9.38
Net Property, Plant and Equip., 5 Yr. CAGR %	16.9	13	16.15	-12.75	0.33
Total Assets, 5 Yr. CAGR %	12.02	7.53	7.41	5.58	8.65
Tangible Book Value, 5 Yr. CAGR %	14.8	4.78	6.28	14.59	14.9
Common Equity, 5 Yr. CAGR %	8.9	3.38	4.92	11.16	12.33
Cash From Operations, 5 Yr. CAGR %	5.25	5.77	4.76	9.51	10.52
Capital Expenditures, 5 Yr. CAGR %	-0.8	-1.01	13.87	2.02	21.34
Levered Free Cash Flow, 5 Yr. CAGR %	0.37	13.41	0.61	17.31	4.67
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.37	13.41	0.61	17.31	4.67